E-Presentation

Refresh Page View All

Exploratory study of prognostic factors in mCRPC patients who administered Enzalutamide focusing on early PSA decline and PSA kinetics at PSA progression; results of retrospective multicenter study

Paper No: 134 | Oncology - Prostate Cancer
Yoshiyuki Miyazawa

3-Minues Oral Presentation 7 | Oncology (Prostate) 3

08 Aug 2019 | 13:30:00-14:30:00

Back to Top